Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Houben

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 2, 2015
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based studyL E Hendriks, J L Derks, P E Postmus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2016
Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapyKrista C J Wink, José S A Belderbos, Edith M T Dieleman, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2011
Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancerV E M Mul, J M A de Jong, L H P Murrer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 29, 2017
Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow upP J A M Brouwers, J van Loon, R M A Houben, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2006
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003M P W A Houben, K K H Aben, J L J M Teepen, et al.
Neurobiology of Aging|May 16, 2006
Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF studyK Sleegers, I de Koning, Y S Aulchenko, et al.
Clinical and Translational Radiation Oncology|March 3, 2025
The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patientsFemke Vaassen, David Hofstede, Catharina M L Zegers, et al.
Annals of Medicine|October 21, 2022
A new prediction model for giant cell arteritis in patients with new onset headache and/or visual lossWalid Moudrous, Leo H Visser, Tansel Yilmaz, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinibVivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imagingCatharina M L Zegers, Wouter van Elmpt, Bart Reymen, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|September 2, 2015
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based studyL E Hendriks, J L Derks, P E Postmus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2016
Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapyKrista C J Wink, José S A Belderbos, Edith M T Dieleman, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2011
Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancerV E M Mul, J M A de Jong, L H P Murrer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 29, 2017
Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow upP J A M Brouwers, J van Loon, R M A Houben, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2006
Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003M P W A Houben, K K H Aben, J L J M Teepen, et al.
Neurobiology of Aging|May 16, 2006
Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF studyK Sleegers, I de Koning, Y S Aulchenko, et al.
Clinical and Translational Radiation Oncology|March 3, 2025
The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patientsFemke Vaassen, David Hofstede, Catharina M L Zegers, et al.
Annals of Medicine|October 21, 2022
A new prediction model for giant cell arteritis in patients with new onset headache and/or visual lossWalid Moudrous, Leo H Visser, Tansel Yilmaz, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinibVivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imagingCatharina M L Zegers, Wouter van Elmpt, Bart Reymen, et al.
Pageof 12